It’s been a while since we’ve visited our “Small But Mighty” series, profiling the many “Mom & Pop companies” run by PWDs for the good of the community. Today we talk with Ryan Brown, a 26-year-old from Tennessee who was dealt a surprising blow when he was diagnosed with type 1 diabetes at age 25. Not not one to sit on his laurels (or sorrows), Ryan decided to use his graphic design talents to launch…Read more »
Dr. Josh Makower is Co-founder of Stanford’s Biodesign Innovation Program, and a Consulting Associate Professor of Medicine at the Stanford University Medical School. He’s also Founder and Chief Executive Officer of ExploraMed, a medical device incubator. And he’s a Venture Partner with New Enterprise Associates, where he supports the investing activity in new medical devices.
In short, Dr. Makower is a world authority on med-tech innovation. I bumped into him while beginning preparations for the…
Nick Jonas. Just whisper his name and you can hear girls screaming across the country, no? With their worldwide music tours, Disney channel TV series, and now making movies, this 18-year-old singer and his two brothers have officially become Larger Than Life.
Nick, who was diagnosed with type 1 diabetes in October 2005, has chosen to devote much of his fame to raising awareness about diabetes. Thanks to the good folks at DiabeticConnect.com and Bayer…
Are you a little bit country? Or a little bit rock n’ roll? Either way, if you have diabetes, you’ll no doubt find inspiration in George Canyon, the Canadian country singer who rocketed to fame as a runner-up in the 2004 Nashville Star 2 reality TV competition. Since then, he’s had two subsequent blockbuster albums — One Good Friend, and Somebody Wrote Love — and become a huge public proponent for JDRF, traveling the US,…Read more »
Many of us patient advocates who make the rounds at e-patient and health 2.0 conferences hear an awful lot of talk about “what the patient wants” and how Pharma and device companies should reach out to our communities online. Meanwhile, they’ve been slow to embrace Social Media, and given the controversy over FDA regulations for this, who knows what’s happening internally at these companies as they struggle to form a viable strategy for getting involved?…Read more »